Evaluated by: David B. Kaminsky, M.D., FIAC, June 25, 2017
Original release date: November 15, 2017
Access to this course expires on: June 23, 2020
Faculty: Lester D.R. Thompson, M.D.
- Become familiar with the new and correct terminology for the diagnosis of sinonasal tract and upper aerodigestive tract lesions based on the new WHO classification.
- Develop reproducible histologic criteria for challenging tumors and dysplasias of the sinonasal tract.
- Decrease the use of broad panels of immunohistochemistry studies, implementing an understanding of focused and selected studies in the diagnosis of sinonasal tract and upper aerodigestive tract lesions.
- Improve understanding of the use of imaging as it applies to "gross" description in sinonasal tract and upper aerodigestive tract pathology.
- Incorporate the selected and targeted use of molecular testing, understanding when it is used for diagnostic versus prognostic consideration.
- Reinforce the multidisciplinary team approach required in the diagnosis and management of complex head and neck and endocrine organ tumors.
- Outline the inclusion and exclusion criteria for noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and make use of an algorithmic approach to diagnosis.
- Review histologic features useful in diagnosing parathyroid gland tumors, especially separating parathyroid adenoma from parathyroid gland carcinoma.
- Implement diagnostic criteria for newly recognized and characterized salivary gland neoplasms, especially as it relates to histologic, immunohistochemical and molecular findings.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
$75.00 - $100.00